Skip to main content
Top

Journal of Endocrinological Investigation

Issue 9/1997

Content (13 Articles)

Different sensitivity to sodium valproate in healthy, non-tumoral and tumoral hyperprolactinemic subjects

F. Sarnacchiaro, A. Colao, B. Merola, A. Di Sarno, M. L. Landi, C. Di Somma, D. Ferone, A. Tolino, Gaetano Lombardi

Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy

Giovanni Murialdo, C. A. Galimberti, F. Magri, P. Sampaolo, F. Copello, M. V. Gianelli, E. Gazzerro, A. Rollero, C. Deagatone, R. Manni, E. Ferrari, A. Polleri, A. Tartara

Sporadic amplification of the insulin receptor gene in human breast cancer

V. Papa, G. Milazzo, I. D. Goldfine, F. M. Waldman, R. Vigneri

Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients

Milena Muratori, M. Arosio, G. Gambino, C. Romano, O. Biella, G. Faglia

Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy

E. Ciccarelli, S. Grottoli, P. Razzore, D. Gaia, A. Bertagna, S. Cirillo, T. Cammarota, M. Camanni, Franco Camanni

Primary hyperparathyroidism-associated polyostotic fibrous dysplasia: Absence of McCune-Albright syndrome mutations

Muhammad M. Hammami, A. Al-Zahrani, A. I. Butt, L. J. Vencer, S. S. Hussain

Comment

The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism

S. Minisola, M. T. Pacitti, R. Rosso, C. Pellegrino, E. Ombricolo, D. Pisani, E. Romagnoli, C. Damiani, G. Aliberti, A. Scarda, S. F. Mazzuoli

Case Report

Lactose intolerance following antithyroid drug medications

L. Petrini, P. Usai, A. Caradonna, R. Cabula, S. Mariotti

Notizie Dalla SocietÀ Italiana di Endocrinologia / News from the Italian Society of Endocrinology

Assemblea Generale della Societá Italiana di Endocrinologia

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.